EC grants orphan drug designation for Gilteritinib for the treatment of AML
The European Commission has issued Orphan Designation to gilteritinib for the treatment of patients with acute myeloid leukaemia...
List view / Grid view
News
Nanoparticle vaccine offers universal protection against influenza
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Combination chemotherapy may significantly improve treatment for glioblastoma
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
Engineers design artificial synapse for ‘brain-on-a-chip’ hardware
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
ROMIL-UpS™ ultra lc solvents and eluant mixes
When you need the ultimate quality, take a look at ROMIL-UpS™ ultra lc solvents and eluants. ROMIL‑UpS™ ultra lc solvents and eluant mixes have been developed to address the challenging requirements of critical analytical applications, such as LC-MS and UHPLC, offering the utmost purity for today’s sensitive instrumentation...
FDA accepts IND for the treatment of mucopolysaccharidosis type IIIA
The FDA has issued a Study may proceed letter for the first study in humans, thereby accepting the investigational new drug application for the drug candidate SOBI003...
Computational method provides a potential boon in fighting antibiotic resistance
A team of computer scientists have developed an algorithm that can rapidly search massive databases to discover novel variants of known antibiotics...
Robotic implant aids the treatment of oesophageal atresia
Engineers have created a robot that can be used to help treat babies with a rare birth defect that affects an infant's oesophagus...
Sanofi to acquire haemophilia specialists Bioverativ for $11.6bn
Sanofi and Bioverativ Inc., have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ...
EC approves first biosimilar Mvasi for the treatment of cancer
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
Fosmidomycin-piperaquine combination provides promising malaria treatment
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
Prescription labels provide insufficient dosing guidance for obese children
Despite providing incentives to drug manufacturers to encourage the study of medications in children, few approved drugs include safe dosing information for obese children...
BM32 vaccine developed against rhinitis
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
Ultra-thin optical fibers offer new way to 3D print microstructures
For the first time, researchers have shown that an optical fiber as thin as a human hair can be used to create microscopic structures with laser-based 3D printing.
Triclosan may help fight drug-resistant malaria
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
